Environmental group raises alarm over polluting Indian drugmakers

31 January 2018
drugs_pills_tablets_big

A report from sustainability non-profit Changing Markets has criticized what it characterizes as uncontrolled pollution from pharmaceuticals manufacturers in India.

The group investigated one of the world’s largest “bulk drug” manufacturing hubs in Hyderabad, which provides large volumes of medications for markets in the USA and in Europe.

Changing markets was asked to conduct a follow up report after negative coverage in 2016 of the environmental impact of companies in the area.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics